GB8907148D0 - Biologically active proteins - Google Patents

Biologically active proteins

Info

Publication number: GB8907148D0
Authority: GB; United Kingdom
Prior art keywords: biologically active; active proteins; proteins; biologically; active
Prior art date: 1988-03-31
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

GB898907148A

Other versions

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Glaxo Group Ltd

Original Assignee

Glaxo Group Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1988-03-31

Filing date

1989-03-30

Publication date

1989-05-10

1989-03-30 Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd

1989-05-10 Publication of GB8907148D0 publication Critical patent/GB8907148D0/en

1989-11-08 Publication of GB2218101A publication Critical patent/GB2218101A/en

Status Withdrawn legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4703—Inhibitors; Suppressors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
- C07K14/7151—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for tumor necrosis factor [TNF], for lymphotoxin [LT]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Toxicology (AREA)
Zoology (AREA)
Epidemiology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Cell Biology (AREA)
General Chemical & Material Sciences (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

GB8907148A 1988-03-31 1989-03-30 TNF-alpha inhibitors Withdrawn GB2218101A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB888807803A GB8807803D0 (en)	1988-03-31	1988-03-31	Biochemical product

Publications (2)

Publication Number	Publication Date
GB8907148D0 true GB8907148D0 (en)	1989-05-10
GB2218101A GB2218101A (en)	1989-11-08

Family

ID=10634493

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
GB888807803A Pending GB8807803D0 (en)	1988-03-31	1988-03-31	Biochemical product
GB8907148A Withdrawn GB2218101A (en)	1988-03-31	1989-03-30	TNF-alpha inhibitors

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
GB888807803A Pending GB8807803D0 (en)	1988-03-31	1988-03-31	Biochemical product

Country Status (12)

Country	Link
JP (1)	JPH02117700A (en)
KR (1)	KR890014125A (en)
AU (1)	AU3228789A (en)
BE (1)	BE1001845A4 (en)
DE (1)	DE3910323A1 (en)
DK (1)	DK156589A (en)
FR (1)	FR2629345A1 (en)
GB (2)	GB8807803D0 (en)
IL (1)	IL89804A0 (en)
IT (1)	IT1232827B (en)
NL (1)	NL8900779A (en)
SE (1)	SE8901115L (en)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL83878A (en) *	1987-09-13	1995-07-31	Yeda Res & Dev	Soluble protein corresponding to tnf inhibitory protein its preparation and pharmaceutical compositions containing it
US5811261A (en) *	1988-09-12	1998-09-22	Yeda Research And Development Co. Ltd.	Expression of the recombinant tumor necrosis factor binding protein I (TBP-I)
EP0393438B1 (en) *	1989-04-21	2005-02-16	Amgen Inc.	TNF-receptor, TNF-binding protein and DNA coding therefor
US6221675B1 (en)	1989-04-21	2001-04-24	Amgen, Inc.	TNF receptors, TNF binding proteins and DNAs coding for them
US7264944B1 (en)	1989-04-21	2007-09-04	Amgen Inc.	TNF receptors, TNF binding proteins and DNAs coding for them
US6143866A (en) *	1989-07-18	2000-11-07	Amgen, Inc.	Tumor necrosis factor (TNF) inhibitor and method for obtaining the same
IL95031A (en) *	1989-07-18	2007-03-08	Amgen Inc	Method for the production of a human recombinant tumor necrosis factor inhibitor
US5605690A (en) *	1989-09-05	1997-02-25	Immunex Corporation	Methods of lowering active TNF-α levels in mammals using tumor necrosis factor receptor
US5395760A (en) *	1989-09-05	1995-03-07	Immunex Corporation	DNA encoding tumor necrosis factor-α and -β receptors
CA2485553A1 (en) *	1989-09-05	1991-03-21	Immunex Corporation	Tumor necrosis factor - .alpha. and - .beta. receptors
US5945397A (en) *	1989-09-05	1999-08-31	Immunex Corporation	Purified p75 (type II) tumor necrosis factor receptor polypeptides
DK0417563T3 (en)	1989-09-12	2000-11-06	Hoffmann La Roche	TNF-binding proteins
US6552170B1 (en)	1990-04-06	2003-04-22	Amgen Inc.	PEGylation reagents and compounds formed therewith
WO1992001002A1 (en) *	1990-07-11	1992-01-23	Teijin Limited	Tumor necrosis factor activity inhibitor and production thereof
US5304634A (en) *	1990-10-12	1994-04-19	Hoechst Aktiengesellschaft	Inhibitors for the formation of tumor necrosis factor
JP2864434B2 (en) *	1991-01-18	1999-03-03	サイナーゲン，インコーポレーテッド	Methods of treating tumor necrosis factor-mediated diseases
JPH06510122A (en) *	1991-08-23	1994-11-10	エヌチップ　インコーポレイテッド	Burn-in techniques for unpackaged integrated circuits
TW555765B (en)	1996-07-09	2003-10-01	Amgen Inc	Low molecular weight soluble tumor necrosis factor type-I and type-II proteins
CA2273852C (en)	1996-12-06	2009-09-29	Amgen Inc.	Combination therapy using an il-1 inhibitor for treating il-1 mediated diseases
ES2207759T3 (en)	1996-12-06	2004-06-01	Amgen Inc.	COMBINATION THERAPY USING A PROTEIN OF UNION OF THE TUMOR NECROSIS FACTOR (TNF) IN THE TREATMENT OF DISEASES Induced by TNF.
US6660843B1 (en)	1998-10-23	2003-12-09	Amgen Inc.	Modified peptides as therapeutic agents
US6808902B1 (en)	1999-11-12	2004-10-26	Amgen Inc.	Process for correction of a disulfide misfold in IL-1Ra Fc fusion molecules
MY143582A (en)	2001-06-26	2011-05-31	Amgent Fremont Inc	Antibodies to opgl
US9028822B2 (en)	2002-06-28	2015-05-12	Domantis Limited	Antagonists against TNFR1 and methods of use therefor
AU2003299971A1 (en)	2002-12-30	2004-07-29	Amgen Inc.	Combination therapy with co-stimulatory factors
US7767206B2 (en)	2006-10-02	2010-08-03	Amgen Inc.	Neutralizing determinants of IL-17 Receptor A and antibodies that bind thereto
TW201117824A (en)	2009-10-12	2011-06-01	Amgen Inc	Use of IL-17 receptor a antigen binding proteins
PT3295957T (en)	2010-01-15	2019-11-12	Kirin Amgen Inc	Anti il-17ra antibody formulation and therapeutic regimens for treating psoriasis
WO2013016220A1 (en)	2011-07-22	2013-01-31	Amgen Inc.	Il-17 receptor a is required for il-17c biology
JP6596014B2 (en)	2014-03-31	2019-10-23	アムジェンケー・エー，インコーポレイテッド	How to treat nail and scalp psoriasis

1988
- 1988-03-31 GB GB888807803A patent/GB8807803D0/en active Pending
1989
- 1989-03-30 DE DE3910323A patent/DE3910323A1/en not_active Withdrawn
- 1989-03-30 IT IT8947794A patent/IT1232827B/en active
- 1989-03-30 IL IL89804A patent/IL89804A0/en unknown
- 1989-03-30 KR KR1019890004087A patent/KR890014125A/en not_active Application Discontinuation
- 1989-03-30 NL NL8900779A patent/NL8900779A/en not_active Application Discontinuation
- 1989-03-30 SE SE8901115A patent/SE8901115L/en not_active Application Discontinuation
- 1989-03-30 GB GB8907148A patent/GB2218101A/en not_active Withdrawn
- 1989-03-30 JP JP1076871A patent/JPH02117700A/en active Pending
- 1989-03-30 FR FR8904160A patent/FR2629345A1/en active Pending
- 1989-03-30 BE BE8900350A patent/BE1001845A4/en not_active IP Right Cessation
- 1989-03-30 DK DK156589A patent/DK156589A/en not_active IP Right Cessation
- 1989-03-30 AU AU32287/89A patent/AU3228789A/en not_active Abandoned

Also Published As

Publication number	Publication date
BE1001845A4 (en)	1990-03-20
NL8900779A (en)	1989-10-16
GB2218101A (en)	1989-11-08
IL89804A0 (en)	1989-09-28
DK156589A (en)	1989-10-01
JPH02117700A (en)	1990-05-02
IT8947794A0 (en)	1989-03-30
IT1232827B (en)	1992-03-05
DK156589D0 (en)	1989-03-30
SE8901115D0 (en)	1989-03-30
AU3228789A (en)	1989-10-05
FR2629345A1 (en)	1989-10-06
DE3910323A1 (en)	1989-10-19
SE8901115L (en)	1989-10-01
GB8807803D0 (en)	1988-05-05
KR890014125A (en)	1989-10-21

Publication	Publication Date	Title
IL89804A0 (en)	1989-09-28	Biologically active proteins
YU163289A (en)	1992-05-28	Recombinant animal somatotropine
HUT46539A (en)	1988-11-28	Biologically active copolimers
IL75828A (en)	1991-06-10	Immobilization by biologically active proteins
GB8817160D0 (en)	1988-08-24	Novel proteins
GB8517300D0 (en)	1985-08-14	Biologically active substances
HU884709D0 (en)	1990-02-28	Biologically active compounds
HUT40167A (en)	1986-11-28	Genes for biologically active proteins
GB8817161D0 (en)	1988-08-24	Modified proteins
GB8430255D0 (en)	1985-01-09	Biologically active oligopeptides
GB8816095D0 (en)	1988-08-10	Protein
EP0253245A3 (en)	1990-04-25	Biologically active peptides tan-866
IE891007L (en)	1989-09-30	Biologically active proteins
GB8806451D0 (en)	1988-04-20	Biologically active molecules
GB8809037D0 (en)	1988-05-18	Biologically active compounds
IE882193L (en)	1989-01-22	Biologically active compounds
IE881005L (en)	1988-10-07	Biologically active compounds
GB8809038D0 (en)	1988-05-18	Biologically active compounds
GB8809034D0 (en)	1988-05-18	Biologically active compounds
GB8423771D0 (en)	1984-10-24	Biologically active peptides
IL108254A0 (en)	1994-04-12	Biologically active conjugates
BG43201A1 (en)	1988-05-16	Biologically active cosmetic means
GB8615040D0 (en)	1986-07-23	Biologically active n heterocycles
GB8615038D0 (en)	1986-07-23	Biologically active n heterocycles
GB8609628D0 (en)	1986-05-21	Biologically active heterocycles

Legal Events

Date	Code	Title	Description
1990-09-12	WAP	Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)